Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Immutep.
RELATED STOCKHEAD STORIES
Health & Biotech
ATO blocks biotech access to Jobkeeper wage subsidy
Health & Biotech
Check up: COVID-19 still sells but investors are looking for the next endorphin hit
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Pharmaxis forges ahead with phase 2 cancer drug trial in spite of COVID-19
Health & Biotech
Cancer clinical trials continue as others are shut down on COVID-19 fears
Health & Biotech
Cyclopharm says radioactive gas could help diagnose COVID-19
Health & Biotech
Health Kick Podcast: Understanding immunotherapy, why the drug market dried up and Immutep’s profitable potential
Health & Biotech
Health: Medlab proves pot reduces a very specific kind of cancer pain
Health & Biotech
Dr Boreham’s Crucible: Investors hawk-eyed as Immutep closes in on breast cancer drug results
Health & Biotech
Biotech: It’s not a get-rich-quick scheme judging by these HY reports
Health & Biotech
